Back
Tenet Healthcare 10K Form
Buy
60
THC
Tenet Healthcare
Last Price:
78.70
Seasonality Move:
-2.87%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2020-10-30 | 10Q | THC/Tenet Healthcare Quarterly |
2020-08-03 | 10Q | THC/Tenet Healthcare Quarterly |
2020-05-04 | 10Q | THC/Tenet Healthcare Quarterly |
2020-02-24 | 10K | THC/Tenet Healthcare Annual |
2019-11-04 | 10Q | THC/Tenet Healthcare Quarterly |
2019-08-05 | 10Q | THC/Tenet Healthcare Quarterly |
Receive THC News And Ratings
See the #1 stock for the next 7 days that we like better than THC
THC Financial Statistics
Sales & Book Value
Annual Sales: | $19.17B |
---|---|
Cash Flow: | $466M |
Price / Cash Flow: | 8.72 |
Annual Sales: | $13.23 |
Price / Book: | 5.95 |
Profitability
EPS (TTM): | 4.55000 |
---|---|
Net Income (TTM): | $499M |
Gross Margin: | $15.9B |
Return on Equity: | 41.31% |
Return on Assets: | 1.85% |
Tenet Healthcare Earnings Forecast
Key Tenet Healthcare Financial Ratios
- The Gross Profit Margin over the past 37 years for THC is 82.93%.
- The Selling, General & Administrative Expenses for THC have been equal to 46.12% of Gross Profit Margin.
- The Research & Development expenses have been 0.00% of Revenue.
- The Interest Expense is 216.55% of Operating Income.
- The Net Earning history of THC is 2.14% of Total Revenues.
- Per Share Earnings over the last 39 years have been positive in 20 years.
Tenet Healthcare Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | S&P500 |
---|---|
Industry: | Medical Care Facilities |
Sector: | Healthcare |
Current Symbol: | THC |
CUSIP: | 88033G |
Website: | tenethealth.com |
Debt
Debt-to-Equity Ratio: | 11.2 |
---|---|
Current Ratio: | 1.44 |
Quick Ratio: | 1.15 |
Price-to-Earnings
Trailing P/E Ratio: | 20.77 |
---|---|
Forward P/E Ratio: | 11.81 |
THC Technical Analysis vs Fundamental Analysis
Buy
60
Tenet Healthcare (THC)
is a Buy
Is Tenet Healthcare a Buy or a Sell?
-
Tenet Healthcare stock is rated a Buy
The current Tenet Healthcare [THC] share price is $78.70. The Score for THC is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.